KM Pharmaceutical, 1 billion won paid-in capital increase allocated to third parties
⚡ Quick Summary
(Seoul = Yonhap News) KM Pharmaceutical [225430], a KOSDAQ listed company, announced on the 14th that it had decided to increase paid-in capital through third-party allocation to raise approximately 1 billion won, including operating funds...